ALX ONCOLOGY HOLDINGS INC Noncash or Part Noncash Acquisition, Fixed Assets Acquired
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $26.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-06
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was -$886.00K.
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $912.00K, a 17.62% decline year-over-year.
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-31 was -$49.00K.
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was -$49.00K.
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $962.00K, a 16.93% decline from fiscal 2024.
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $1.16M, a 17.70% decline from fiscal 2023.
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $1.41M, a 34.41% decline from fiscal 2022.
- ALX ONCOLOGY HOLDINGS INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $2.15M, a 805.06% increase from fiscal 2021.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$886.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $26.00K 10-Q · filed 2026-08-06 | -$23.00K derived: sum of 3 quarters · filed 2026-08-06 | -$72.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $912.00K 10-Q · filed 2026-05-08 | $863.00K derived: sum of 2 quarters · filed 2026-05-08 | $814.00K derived: sum of 3 quarters · filed 2026-05-08 | $767.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$98.00K derived: sum of 2 quarters · filed 2026-03-09 | -$145.00K derived: sum of 3 quarters · filed 2026-08-06 | $962.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$96.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.01M 10-Q · filed 2025-11-07 | $958.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.06M 10-Q · filed 2026-08-06 | $1.01M derived: sum of 3 quarters · filed 2026-08-06 | $878.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.11M 10-Q · filed 2026-05-08 | $1.05M derived: sum of 2 quarters · filed 2026-05-08 | $925.00K derived: sum of 3 quarters · filed 2026-05-08 | $930.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$182.00K derived: sum of 2 quarters · filed 2026-03-09 | -$177.00K derived: sum of 3 quarters · filed 2026-03-09 | $1.16M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$124.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.21M 10-Q · filed 2025-11-07 | $1.24M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.34M 10-Q · filed 2025-08-12 | $1.37M derived: sum of 3 quarters · filed 2026-03-09 | $2.67M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $1.33M 10-Q · filed 2025-05-08 | $1.37M derived: sum of 2 quarters · filed 2026-03-09 | $2.67M derived: sum of 3 quarters · filed 2026-03-09 | $1.03M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.33M derived: sum of 2 quarters · filed 2026-03-09 | -$304.00K derived: sum of 3 quarters · filed 2026-03-09 | $1.41M 10-K · filed 2026-03-09 |
| 2023-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$335.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.38M 10-Q · filed 2024-11-07 | $2.65M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $75.00K 10-Q · filed 2024-08-12 | $1.34M derived: sum of 3 quarters · filed 2025-03-06 | $1.95M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | $1.71M 10-Q · filed 2024-05-09 | $2.98M derived: sum of 2 quarters · filed 2025-03-06 | $3.59M derived: sum of 3 quarters · filed 2025-03-06 | $3.71M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.88M derived: sum of 2 quarters · filed 2025-03-06 | $2.00M derived: sum of 3 quarters · filed 2025-03-06 | $2.15M 10-K · filed 2025-03-06 |
| 2022-09-30 | $610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $729.00K derived: sum of 2 quarters · filed 2023-08-10 | $876.00K 10-Q · filed 2022-11-08 | $984.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $266.00K 10-Q · filed 2023-08-10 | $374.00K derived: sum of 3 quarters · filed 2024-03-07 | $376.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $147.00K 10-Q · filed 2023-05-11 | $255.00K derived: sum of 2 quarters · filed 2024-03-07 | $257.00K derived: sum of 3 quarters · filed 2024-03-07 | |
| 2021-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $110.00K derived: sum of 2 quarters · filed 2024-03-07 | $237.00K 10-K · filed 2024-03-07 | |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $129.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $127.00K 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $7.00K 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-12 | |||
| 2018-12-31 | $20.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |